Search

AIM: The objective of the present study was to screen for hearing loss and to document the importance of using Transient Evoked Otoacoustic Emissions as a screening tool for hearing loss. MATERIAL AND METHODS: The descriptive study was conducted during the period August 2012 to July 2014 in a tertiary care health center. A study group consisting of 500 infants were subjected to TEOAE at 24-72 hours after birth. For pass cases no further testing was done. For refer cases repeat TEOAE testing was done at 15-30days, failing which such infant was subjected to Brainstem Evoked Response testing within 3 months to confirm hearing loss. RESULT: Five hundred infants were screened by TEOAE's after 24 hours of birth. 29 infants had refer result for 1st TEOAE hearing screen and for these infants repeat TEOAE screen was done at 15-30 days of age. On repeat TEOAE testing, 1 infant gave refer result. Then 19 infants including 18 high risk babies and 1 well baby were subjected to BERA testing within 3 months. On testing with BERA only 5 infants showed hearing loss. Hence the prevalence of hearing loss of 2 per thousand was detected in well babies and 22.2 per hundred in high risk babies. Hence substantiating the need to develop a method for screening infants for hearing loss. CONCLUSION: Hence the use of Transient Evoked Otoacoustic Emissions as initial screening test provides as easy, cost effective and quick method to detect infants with hearing loss.

AIM: The objective of the present study was to screen for hearing loss and to document the importance of using Transient Evoked Otoacoustic Emissions as a screening tool for hearing loss. MATERIAL AND METHODS: The descriptive study was conducted during the period August 2012 to July 2014 in a tertiary care health center. A study group consisting of 500 infants were subjected to TEOAE at 24-72 hours after birth. For pass cases no further testing was done. For refer cases repeat TEOAE testing was done at 15-30days, failing which such infant was subjected to Brainstem Evoked Response testing within 3 months to confirm hearing loss. RESULT: Five hundred infants were screened by TEOAE's after 24 hours of birth. 29 infants had refer result for 1st TEOAE hearing screen and for these infants repeat TEOAE screen was done at 15-30 days of age. On repeat TEOAE testing, 1 infant gave refer result. Then 19 infants including 18 high risk babies and 1 well baby were subjected to BERA testing within 3 months. On testing with BERA only 5 infants showed hearing loss. Hence the prevalence of hearing loss of 2 per thousand was detected in well babies and 22.2 per hundred in high risk babies. Hence substantiating the need to develop a method for screening infants for hearing loss. CONCLUSION: Hence the use of Transient Evoked Otoacoustic Emissions as initial screening test provides as easy, cost effective and quick method to detect infants with hearing loss.

Byline: Anju. Bhalotra, Rohit. Balyan, Gunjan. Manchanda, Shefali. Singh Sir, Anaesthesia for children with temporomandibular joint (TMJ) ankylosis presents a challenge. Two children, age 6 and 7 years, weighing 14 [...]

Background: Soft tissues of the head and neck areas are a very frequent site of occurrence of certain benign tumors of the peripheral nerve sheath, especially the neurofibromas. Hence, the present study was conducted for assessing clinical, radiographic, and treatment profile of 10 cases of neurogenic tumors and tumor-like lesions of the oral and maxillofacial region. Materials and Methods: Data records of a total of 10 patients who were diagnosed with tumors of neurogenic origin were enrolled in the present study. Data files were analyzed over a time period of 2 years, and complete clinical and radiographic details were evaluated. All the patients in which incomplete information was present in the record files were excluded from the present study. The assessment of the histopathologic reports was done, and final diagnosis was recorded separately in the master chart. Results: Neurofibroma was the diagnosis in two cases. In another set of two cases, final diagnosis of traumatic neuroma was achieved. A single case Schwannoma of mandible depicting multilocular radiolucency was present. Granular cell tumor was present in three cases. It was present clinically in the form of swelling, ulcerative nodule, and nodular growth in the three respective cases. Surgical excision was carried out in all the cases, and follow-up records did not depict any case of recurrence of complication posttreatment. Conclusion: Neurogenic tumors of oral and maxillafacial region are a rare phenomenon and mainly present in the form of benign neoplasm. However, careful recognition and diagnosis of these lesions are necessary to rule any possible malignant changes. [ABSTRACT FROM AUTHOR]

Byline: Gunjan. Manchanda, Anju. Bhalotra, Poonam. Bhadoria, Aarti. Jain, Preeti. Goyal, Mona. Arya Laparoscopic procedures are becoming increasingly widespread as more and more surgical procedures are becoming amenable to laparoscopic [...]